Presentation Information
[BO-1]Management of patients with hematological disorders with germline predispositions in Japan
○Mizuki Watanabe1,2, Junya Kanda1, Hidenori Kawasaki3, Senji Kasahara4, Nobuhiro Kanemura5, Norihiro Hiramoto6, Kensuke Usuki7, Kazunori Imada8, Yasunori Ueda9, Kinuko Mitani10, Tosiyuki Kitano11, Yukiyoshi Moriuchi12, Uoshima Nobuhiko13, Shigeo Fuji14, Seishi Ogawa15, Akifumi Takaori1, Yasuhito Nannya16 (1.Department Hematology, Kyoto University Hospital, Kyoto, Japan, 2.Div. Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan, 3.Clinical Genetics Unit, Kyoto University Hospital, Kyoto, Japan, 4.Department of Hematology, Gifu Municipal Hospital, Gifu, Japan, 5.Department Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan, 6.Department Hematology, Kobe City Medical Center General Hospital, Kobe, Japan, 7.Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan, 8.Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan, 9.Department of Hematology, Kurashiki Central Hospital, Kurashiki, Japan, 10.Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan, 11.Department of Hematology, Kitano Hospital, Osaka, Japan, 12.Department of Hematology, Sasebo City General Hospital, Sasebo, Japan, 13.Department Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan, 14.Department of Hematology, Osaka International Cancer Institute, Osaka, Japan, 15.Department Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 16.Department Hematology/Oncology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan)